Harvard Medicine home webweekly
May 23, 2005

In Print


Mark T. Keating (right) and Felix Engel
Photo by Graham Ramsay

From Focus:
Broken Hearts May Mend After All
Adult cardiac muscle cells refuse to divide and renew after injury from heart failure, the primary cause of death in the developed world. But a team led by Mark T. Keating (right) and Felix Engel announces it has accomplished a long-sought goal: coaxing adult mammalian cardiomyocytes to divide and proliferate. Their achievement is a first step in trying to accomplish the same feat in a living animal and suggests a molecular pathway for repairing a damaged heart after injury.


Upcoming

5th Annual Marshall J. Seidman Lecture on Health Policy
William H. Frist
United States Senate
Wednesday, June 1
1:30–2:45 pm


Lab Works

A multimedia site featuring Harvard Medical research.


StudenTalk

Personal takes on issues inside and outside the classroom.

 

Spotlight


Judah Folkman (right) and Alan Retik
Photos by Liza Green, HMS Media Services Department

HMS and Children’s Announce New Endowed Chairs
Two new endowed chairs at HMS and Children’s take the names of HMS faculty members at the hospital, Judah Folkman (right) and Alan Retik.


Student Scene

Joseph Ladapo
Photo by Patrick Ladapo

Weighing In on the CDC’s Latest Obesity Study
Joseph Ladapo believes that the CDC’s recent downward revision of mortality figures associated with excess weight is likely to shift the cautionary health policy message from risk of death to reduced quality of life and risk of disease.

Headlines

News from HMS and Its Affiliates

Aspirin Use May Protect Against Colon Cancer Recurrence, Reduce Risk of Death

Test Predicts Risk of Blood Clot in Women Receiving Tamoxifen Therapy for Breast Cancer

Exercise Reduces Risk of Recurrence and Death in Early Stage Colon Cancer Patients

Breast Tumor’s Biological Traits Guide Hormone Therapy

Moderate Alcohol Use Linked to Increase in Breast Cancer Risk

New Targeted Therapy Helps Patients Once Gleevec Fails in Gastrointestinal Cancer

Drug Combination Boosts Survival Rate In Head and Neck Cancers

New Class of Drugs May Treat Lung Tumors Resistant to Iressa and Tarceva

Left- or Right-Brain? Genes May Tell the Story (Click on “In Research”)


Back Issues

Online Publications

Calendar

HMS Home

InteliHealth

Feedback